It remains wise to buy Reckitt Benckiser's product and, despite a fall today, its shares
By Chris Bailey | Wednesday 26 October 2022
Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
I guess I have been a professional analyst and investor for the last twenty-six years, but obviously as a buy side and not a sell side operator. As I may have said before, I learnt early on that the more I could ignore brokers and do my own research, the better I would do. And that still remains my thought today as I still think, a bit like the academic world, the biggest risk is that you end up knowing more and more about less and less. And that brings us to today’s Q3 update from Reckitt Benckiser (RKT).
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism
Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.